Meningococcemia

Infectious Disease Clinics of North America

Volumn 10, Issue 4, 1996, Pages 709-725

  Salzman, M B ^a   Rubin, L G ^a  

^a SCHNEIDER CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTRIAXONE; CORTICOSTEROID; PENICILLIN G;

ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CHEMOPROPHYLAXIS; CLINICAL FEATURE; DISEASE TRANSMISSION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; RESUSCITATION; SEPTICEMIA; SKIN MANIFESTATION; VACCINATION;

EID: 0030462654     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70323-8     Document Type: Article

References (91)

1. J.S. Abramson J.S. Spika Persistence of Neisseria meningitidis in the upper respiratory tract after intravenous antibiotic therapy for systemic meningococcal disease J Infect Dis 151 1985 370
2. B.M. Andersen Mortality in meningococcal infections Scand J Infect Dis 10 1978 277
3. M.A. Apicella Neisseria meningitidis Mandell G.L. Douglas R.G. Bennett J.E. Principles and Practice of Infectious Diseases ed 4 1995 Churchill Livingstone New York 1896
4. M.S. Artenstein R. Gold J.G. Zimmerly Prevention of meningococcal disease by group C polysaccharide vaccine N Engl J Med 282 1970 417
5. R.A. Baker J.H. Seguin N. Leslie Fever and petechiae in children Pediatrics 84 1989 1051
6. L.J. Baraff S.I. Lee Fever without source: Management of children 3 to 36 months of age Pediatr Infect Dis J 11 1992 146
7. C. Best J. Walsh J. Sinclair Early haemo-diafiltration in meningococcal septicemia Lancet 347 1996 202
8. D.J. Bihari J. Tinker The therapeutic value of vasodilator prostaglandins in multiple organ failure associated with sepsis Intensive Care Med 15 1988 2
9. G. Bjune E.A. Hoiby J.K. Gronnesby Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway Lancet 338 1991 1093
10. R.C. Bone C.J. Fisher T.P. Clemmer A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock N Engl J Med 317 1987 653
11. J.W. Boslego E.C. Tramont Neisseria meningitidis Gorbach S.L. Bartlett J.G. Blacklow N.R. Infectious Diseases 1992 WB Saunders Philadelphia 1452
12. P. Brandtzaeg P. Kierulf P. Gaustad Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease J Infect Dis 159 1989 195
13. C.V. Broome The carrier state: Neisseria meningitidis. J Antimicrob Chemother 18 suppl A 1986 25
14. G.E. Buck M. Adams Meningococcus with reduced susceptibility to penicillin isolated in the United States Pediatr Infect Dis J 13 1994 156
15. J. Campos G. Trujillo T. Seuba Discriminative criteria for Neisseria meningitidis isolates that are moderately susceptible to penicillin and ampicillin Antimicrob Agents Chemother 36 1992 1028
16. J.A. Carcillo A.L. Davis A. Zaritsky Role of early fluid resuscitation in pediatric septic shock JAMA 266 1991 1242
17. K.A.V. Cartwright D.M. Jones A.J. Smith Influenza A and meningococcal disease Lancet 338 1991 554
18. P.P. Castagliuolo R. Nisini I. Quinti Immunoglobulin deficiencies and meningococcal disease Ann Allergy 57 1986 68
19. D.A. Caugant E.A. Hoiby P. Magnus Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population J Clin Microbiol 32 1994 323
20. Centers for Disease Control and Prevention Availability of meningococcal vaccine in single-dose vials for travelers and high-risk persons MMWR Morb Mortal Wkly Rep 39 1990 763
21. Centers for Disease Control and Prevention Laboratory-based surveillance for meningococcal disease in selected areas—United States, 1989–1991 MMWR Morb Mortal Wkly Rep 42 1993 21
22. Committee on Infectious Diseases, American Academy of Pediatrics Meningococcal infections Peter G. Report of the Committee on Infectious Diseases ed 23 1994 American Academy of Pediatrics Elk Grove Village, IL 325
23. J.J. Corrigan C.M. Jordan Heparin therapy in septicemia with disseminated intravascular coagulation N Engl J Med 283 1970 778
24. L.E. Cuevas P. Kazembe G.K. Mughogho Eradication of nasopharyngeal carriage of Neisseria meningitidis in children and adults in rural Africa: A comparison of ciprofloxacin and rifampicin J Infect Dis 171 1995 728
25. de Moraes J.C. B.A. Perkins M.C.C. Camargo Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil Lancet 340 1992 1054
26. De Wals P. L. Hertoghe I. Borlee-Grimee Meningococcal disease in Belgium. Secondary attack rate among household, day care nursery, and pre-elementary school contacts J Infect 3 suppl 1 1981 53
27. M.S. Drapkin J.S. Wisch J.A. Gelfand Plasmapheresis for fulminant meningococcemia Pediatr Infect Dis J 8 1989 399
28. T.M. Drew R. Altman K. Black Minocycline for prophylaxis of infection with Neisseria meningitidis: High rate of side effects in recipients J Infect Dis 133 1976 194
29. D.V. Esso D. Fontanals S. Uriz Neisseria meningitidis strains with decreased susceptibility to penicillin Pediatr Infect Dis J 6 1987 438
30. J.E. Figueroa P. Densen Infectious diseases associated with complement deficiencies Clin Microbiol Rev 4 1991 359
31. E.L. Francke H.C. Neu Postsplenectomy infection Surg Clin North Am 61 1981 135
32. C.E. Frasch Vaccines for prevention of meningococcal disease Clin Microbiol Rev 2 1989 S134
33. P.N. Gaunt B.E. Lambert Single dose ciprofloxacin for the eradication of pharyngeal carriage of Neisseria meningitidis. J Antimicrob Chemother 21 1988 489
34. O.H. Gilja A. Halstensen A. Digranes Use of single-dose ofloxacin to eradicate tonsillopharyngeal carriage of Neisseria meningitidis. Antimicrob Agents Chemother 37 1993 2024
35. E. Girardin G.E. Grau J.M. Dayer Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura N Engl J Med 319 1988 397
36. M.P. Glode A.L. Smith Meningococcal disease Feigin R.D. Cherry J.D. Textbook of Pediatric Infectious Diseases ed 3 1992 WB Saunders Philadelphia 1185
37. I. Goldschneider E.C. Gotschlich M.S. Artenstein Human immunity to the meningococcus J Exp Med 129 1969 1307
38. R.B. Guttler G.W. Counts C.K. Avent Effect of rifampin and minocycline on meningococcal carrier rates J Infect Dis 124 1971 199
39. C.A. Hart L.E. Cuevas P. Kazembe The use of ciprofloxacin to eradicate oropharyngeal carriage of Neisseria meningitidis: A preliminary analysis Adv Antimicrob Antineoplastic Chemother 11 1992 167
40. C.A. Hart T.R.F. Rogers Meningococcal disease J Med Microbiol 39 1993 3
41. B. Hubert L. Watter P. Garnerin Meningococcal disease and influenza-like syndrome: A new approach to an old question J Infect Dis 166 1992 542
42. L.A. Jackson A. Shuchat M.W. Reeves Serogroup C meningococcal outbreaks in the United States. An emerging threat JAMA 273 1995 383
43. L.A. Jackson F.C. Tenover C. Baker Prevalence of Neisseria meningitidis relatively resistant to penicillin in the United States, 1991 J Infect Dis 169 1994 438
44. H.S. Jafari G.H. McCracken Sepsis and septic shock: A review for clinicians Pediatr Infect Dis J 11 1992 739
45. M.E. Kingston D. Mackey Skin clues in the diagnosis of life-threatening infections Rev Infect Dis 8 1986 1
46. B.-E. Kristiansen A.-B. Knapskog Secondary prevention of meningococcal disease BMJ 312 1996 591
47. D.W. Kuhns C.T. Nelson H.A. Feldman The prophylactic value of sulfadiazine in the control of meningococcic meningitis JAMA 123 1943 335
48. T.J.A. Lehman B. Bernstein V. Hanson Meningococcal infection complicating systemic lupus erythematosus J Pediatr 99 1981 94
49. W.A. Lynn J. Cohen Adjunctive therapy for septic shock: A review of experimental approaches Clin Infect Dis 20 1995 143
50. S.G. Manios F. Kanakoudi E. Maniati Fulminant meningococcemia. Heparin therapy and survival rate Scand J Infect Dis 3 1971 127
51. G.H. McCracken Rapid identification of specific etiology in meningitis J Pediatr 88 1976 706
52. J.C. Mercier F. Beaufils J.F. Hartmann Hemodynamic patterns of meningococcal shock in children Crit Care Med 16 1988 27
53. J. Merino V. Rodriguez-Valverde J.A. Lamelas Prevalence of deficits of complement components in patients with recurrent meningococcal infections J Infect Dis 148 1983 331
54. C.J. Migeon F.M. Kenny W. Hung Study of adrenal function in children with meningitis Pediatrics 40 1967 163
55. F. Monsalve L. Rucabado A. Salvador Myocardial depression in septic shock caused by meningococcal infection Crit Care Med 12 1984 1021
56. P.S. Moore J. Hierholzer W. DeWitt Respiratory virus and Mycoplasma as cofactors for epidemic group A meningococcal meningitis JAMA 264 1990 1271
57. Munford R.S. Sussuarana de Vasconcelos Z.J. C.J. Phillips Eradication of carriage of Neisseria meningitidis in families: A study in Brazil J Infect Dis 129 1974 644
58. R.S. Munford A.E. Taunay J.S. Morais Spread of meningococcal infection within households Lancet 1 1974 1275
59. Q.V. Nguyen E.A. Nguyen L.B. Weiner Incidence of invasive bacterial disease in children with fever and petechiae Pediatrics 74 1984 77
60. H. Ni A.I. Knight K. Cartwright Polymerase chain reaction for the diagnosis of meningococcal meningitis Lancet 340 1992 1432
61. J.R. Oakley A.N. Stanton Meningococcal infections during infancy: Confidential inquiries into 10 deaths BMJ 2 1979 468
62. H. Peltola P.H. Makela H. Kayhty Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children 3 months to 5 years of age N Engl J Med 297 1977 686
63. E. Perez-Trallero L. Aldamiz-Echeverria E.G. Perez-Yarza Meningococci with increased resistance to penicillin Lancet 335 1990 1096
64. Podgore JK, El-Refai M, Girgis NI, et al: Randomized evaluation of cefixime versus rifampin for the eradication of N. meningitidis pharyngeal carriage in a closed population [abstract 1024]. In Programs and Abstracts of the 31st Interscience Conference of Antimicrobial Agents and Chemotherapy, Chicago, September 29–October 2, 1991, p 269.
65. H.M. Pollock Meningococcal infections Balows A. Hausler W.J. Ohashi M. Laboratory Diagnosis of Infectious Diseases. Principles and Practice 1988 Springer-Verlag New York 375
66. G.E. Rivard M. David C. Farrell Treatment of purpura fulminans in meningococcemia with protein C concentrate J Pediatr 126 1995 646
67. J.A. Schifferli M. Pascual P. Delemont Meningococcemia in a patient with acquired complement deficiency and myeloma N Engl J Med 311 1984 1381
68. E.D. Shapiro N.H. Aaron E.R. Wald Risk factors for development of bacterial meningitis among children with occult bacteremia J Pediatr 109 1986 15
69. J.F. Sinclair C.H. Skeoch D. Hallworth Prognosis of meningococcal septicaemia Lancet 2 1987 38
70. R.E. Stanwell-Smith J.M. Stuart A.O. Hughes Smoking, the environment and meningococcal disease: A case-control study Epidemiol Infect 112 1994 315
71. E.R. Stiehm D.S. Damrosch Factors in the prognosis of meningococcal infection J Pediatr 68 1966 457
72. J.R. Strang E.J. Pugh Meningococcal infections: Reducing the case fatality rate by giving penicillin before admission to hospital BMJ 305 1992 141
73. T.D. Sullivan L.J. LaScolea Neisseria meningitidis bacteremia in children: Quantitation of bacteremia and spontaneous clinical recovery without antibiotic therapy Pediatrics 80 1987 63
74. The Meningococcal Disease Surveillance Group Analysis of endemic meningococcal disease serogroup and evaluation of chemoprophylaxis J Infect Dis 134 1976 201
75. The Meningococcal Disease Surveillance Group Meningococcal disease. Secondary attack rate and chemoprophylaxis in the United States, 1974 JAMA 235 1976 261
76. A.P.J. Thomson J.A. Sills C.A. Hart Validation of the Glasgow Meningococcal Septicemia Prognostic Score: A 10-year retrospective survey Crit Care Med 19 1991 26
77. P.C. Turner K.W. Southern N.J.B. Spencer Treatment failure in meningococcal meningitis Lancet 335 1990 732
78. Twumasi P.A. Jr S. Kumah A. Leach A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants J Infect Dis 171 1995 632
79. S. Uriz V. Pineda M. Grau Neisseria meningitidis with reduced sensitivity to penicillin: Observations in 10 children Scand J Infect Dis 23 1991 171
80. van Deuren M. F.W. Santman van Dalen R. Plasma and whole blood exchange in meningococcal sepsis Clin Infect Dis 15 1992 424
81. L. Voss D. Lennon Epidemiology, management, and prevention of meningococcal infections Curr Opin Pediatr 6 1994 23
82. A. Waage P. Brandtzaeg A. Halstensen The complex pattern of cytokines in serum from patients with meningococcal septic shock J Exp Med 169 1989 333
83. A. Waage A. Halstensen T. Espevik Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease Lancet 1 1987 355
84. C.E. Weidner T.B. Dunkel F.S. Pettyjohn Effectiveness of rifampin in eradicating the meningococcal carrier state in a relatively closed population: Emergence of resistant strains J Infect Dis 124 1971 172
85. N. Weis I. Lind Pharyngeal carriage of Neisseria meningitidis before and after treatment of meningococcal disease J Med Microbiol 41 1994 339
86. R.G.J. Westendorp J.A.M. Langermans de Bel E.C. Release of tumor necrosis factor: An innate host characteristic that may contribute to the outcome of meningococcal disease J Infect Dis 171 1995 1057
87. C.R. Woods A.L. Smith B.L. Wasilauskas Invasive disease caused by Neisseria meningitidis relatively resistant to penicillin in North Carolina J Infect Dis 170 1994 453
88. P. Yagupsky S. Ashkenazi C. Block Rifampicin-resistant meningococci causing invasive disease and failure of prophylaxis Lancet 341 1993 1152
89. E.J. Young T.A. Cardella Meningococcemia diagnosed by peripheral blood smear JAMA 260 1988 992
90. W. Zenz W. Muntean S. Gallistl Recombinant tissue plasminogen activator treatment in two infants with fulminant meningococcemia Pediatrics 96 1995 144
91. J.J. Zimmerman K.A. Dietrich Current perspectives on septic shock Pediatr Clin North Am 34 1987 131